Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
William Blair Upgrades Infinity Pharmaceutical (INFI) to Outperform
August 6, 2014 8:39 AM EDTWilliam Blair upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $9.98 yesterday.
... More


